介绍了在喘中失去皮质类固醇信用的概念
1Hospital de G Baigorria, Universidad Nacional de Rosario, Granadero Baigorria, Argentina.
概括
系统性皮质类固醇 (SCS) 在喘中增加并发病和死亡的风险,即使在低累积剂量. 对SCS风险和替代方案的认识对于患者的安全和改善喘管理至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 系统性皮质类固醇 (SCS) 广泛用于喘管理.
- 广泛使用SCS与显著的并发症和增加的死亡率有关.
- 在SCS暴露和不良结果之间存在剂量反应关系.
研究的目的:
- 引入"SCS信贷"概念,提高人们对SCS风险的认识.
- 促进在喘护理中采用更安全的治疗替代方案.
- 量化累积SCS暴露对患者发病率和死亡率的影响.
主要方法:
- 对累计SCS暴露的剂量反应关系的分析.
- 评估与不同的SCS暴露水平相关的不良结果.
- 与SCS信贷消费相关的发病率和死亡率的评估.
主要成果:
- 在1.0-2.5g的累积SCS暴露下,不良结果和死亡风险显著增加.
- 这种暴露水平相当于大约四个终身SCS课程.
- 超过1.5g/年的终身SCS信贷,会显著提高发病率和死亡率.
结论:
- "SCS信贷"概念强调了系统性皮质类固醇在喘中的累积风险.
- 对这些风险的认识可以推动使用替代性,更安全的治疗方法.
- 尽量减少累积的SCS暴露对于减少喘患者的长期不良健康影响至关重要.
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
232
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
232
Asthma: Pathogenesis and Management
378
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
378
COPD: Management Using Bronchodilators and Corticosteroids
192
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
192
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


